Position in ZTS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$7,785,901
-$10,953,855 QoQ
Shares Held
65,865
-55.8% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026NATIXIS ADVISORS, LLC holds $166,492,947 across 17 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
9,198,299 | $92,074,972 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
565,862 | $17,043,763 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
253,753 | $15,039,940 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
15,249 | $9,042,352 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
65,865 | $7,785,901 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
324,034 | $6,001,109 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
43,597 | $5,743,468 | |
| 8 | VTRS |
Viatris Inc
|
234,320 | $3,165,663 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,785,901 | 65,865 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $18,739,756 | 148,941 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $65,454,788 | 447,340 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $137,077,242 | 878,982 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $154,100,050 | 935,925 | Shares | Other | 2025-05-08 | |
| 2024-12-31 | $139,452,927 | 855,907 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $219,080,766 | 1,121,306 | Shares | Other | 2024-11-06 | |
| 2024-06-30 | $188,771,529 | 1,088,899 | Shares | Other | 2024-08-01 | |
| 2024-03-31 | $175,143,856 | 1,035,068 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $186,004,053 | 942,413 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $163,753,280 | 941,219 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $105,336,723 | 611,676 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $97,966,750 | 588,601 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $72,215,590 | 492,771 | Shares | Defined | 2023-01-27 | |
| 2022-09-30 | $62,921,967 | 424,317 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $73,920,091 | 430,043 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $71,168,019 | 377,369 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $94,836,158 | 388,625 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $71,767,733 | 369,670 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $71,718,223 | 384,837 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $56,297,052 | 357,487 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $59,693,036 | 360,683 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $46,078,035 | 278,636 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $38,600,193 | 281,671 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $27,093,297 | 230,209 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||